'Patients are suffering': After 15 days of protests, Delhi resident doctors call off strike

-

After 15 days, Delhi’s resident doctors — who have been refusing to offer medical services — have decided to call off their strike today.

The resident doctors in Delhi, who were protesting over the delay in NEET-PG counselling and alleged manhandling of doctors by the police, said they will resume work from 12 pm on Friday.

“The strike has been called off. We will rejoin work at 12 pm. We had a meeting with the joint commissioner of police (CP) last night where he gave instructions to cancel the FIR. As for the NEET-PG, we have been assured that the court clearance will come during the 6 January hearing,” said Dr Manish Kumar, president, Federation of Resident Doctors Association (FORDA).

Resident doctors in the National Capital have been protesting for the past 15 days, leading to medical facilities being disrupted across hospitals.

The protests turned violent on Monday night when the junior doctors, who were on a march towards the Supreme Court, had been stopped by the Delhi Police. The situation descended into chaos, as doctors alleged they were lathi-charged by the authorities, a charge which has been denied by them.

Digging down, the resident doctors then refused to resume work till an apology was provided to them and on Tuesday, 28 December, resident doctors belonging to FORDA gathered in large numbers on the premises of Centre-run Safdarjung Hospital and raised slogans like 'We want justice'.

Patient care remained affected at three Centre-run facilities — Safdarjung, RML and Lady Hardinge hospitals and some other Delhi government-run hospitals too.

The Centre-run Safdarjung Hospital, which was the epicenter of the ongoing stir, witnessed chaos as the OPD counters remained shut. The doctors protested outside the emergency ward and all emergency services were obstructed. Even the ambulance services have been disrupted by the agitating doctors.

With inputs from agencies

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.



from Firstpost India Latest News https://ift.tt/3mNkXPQ
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more